RPID | Rapid Micro Biosystems, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.8300 - 0.8551
52 Week Range	0.5800 - 1.1800
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	93,761
Average Volume	54,508
Shares Outstanding	42,914,149
Market Cap	35,876,229
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2021-07-15

Valuation
Profitability
Growth
Health
P/E Ratio	-0.71
Forward P/E Ratio	N/A
EPS	-1.17
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	193
Country	USA
Website	RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

RPID's peers: AEMD, BBLG, BVS, CERS, CODX, ECOR, HSDT, MXCT, MYO, NAOV, NSPR, OWLT, QTRX, RXST, AXGN, TMCI, LUNG, OFIX, AZYO, AIMD, SRDX, LNSR, IRIX, OSA, LIVN, ELMD, KIDS, INVO, TLIS, TIVC, BJDX, VVOS, SGHT, SIBN, UFPT

*Chart delayed

Analyzing fundamentals for RPID we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see RPID Fundamentals page.

Watching at RPID technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on RPID Technicals page.